Literature DB >> 25665765

ST2 in Pulmonary Disease.

Ednan K Bajwa1, Alexandre Mebazaa2, James L Januzzi3.   

Abstract

In recent years, numerous studies have focused on the use of soluble ST2 (sST2) as a clinical biomarker for cardiovascular disease. However, much preclinical data points to involvement of the ST2 pathway in inflammation, and specifically in pulmonary inflammation. This report summarizes the current body of clinical data suggesting the potential role of the ST2 pathway in clinical disease, including evidence that sST2 could be a useful biomarker in both allergic and nonallergic pulmonary disease.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25665765     DOI： 10.1016/j.amjcard.2015.01.040

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  7 in total

1.  The emerging role of sST2 blocking in the therapy of graft-versus-host disease.

Authors:  Yifan Xiao; Fang Zheng
Journal:  Ann Transl Med       Date:  2016-10

2.  Diagnostic and Prognostic Plasma Biomarkers for Idiopathic Pneumonia Syndrome after Hematopoietic Cell Transplantation.

Authors:  Sachiko Seo; Jeffrey Yu; Isaac C Jenkins; Wendy M Leisenring; Terry Steven-Ayers; Jane M Kuypers; Meei-Li Huang; Keith R Jerome; Michael Boeckh; Sophie Paczesny
Journal:  Biol Blood Marrow Transplant       Date:  2017-12-06       Impact factor: 5.742

3.  Plasma Concentrations of Soluble Suppression of Tumorigenicity-2 and Interleukin-6 Are Predictive of Successful Liberation From Mechanical Ventilation in Patients With the Acute Respiratory Distress Syndrome.

Authors:  Jehan W Alladina; Sean D Levy; Kathryn A Hibbert; James L Januzzi; R Scott Harris; Michael A Matthay; B Taylor Thompson; Ednan K Bajwa
Journal:  Crit Care Med       Date:  2016-09       Impact factor: 7.598

4.  Plasma Soluble Suppression of Tumorigenicity-2 Associates with Ventilator Liberation in Acute Hypoxemic Respiratory Failure.

Authors:  Jehan Alladina; Sean D Levy; Josalyn L Cho; Kelsey L Brait; Sowmya R Rao; Alexander Camacho; Kathryn A Hibbert; R Scott Harris; Benjamin D Medoff; James L Januzzi; B Taylor Thompson; Ednan K Bajwa
Journal:  Am J Respir Crit Care Med       Date:  2021-05-15       Impact factor: 21.405

5.  ST2 Predicts Mortality In Patients With Acute Hypercapnic Respiratory Failure Treated With Noninvasive Positive Pressure Ventilation.

Authors:  Brynja Jónsdóttir; Marie Ziebell Severinsen; Fredrik von Wowern; Carmen San Miguel; Jens P Goetze; Olle Melander
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-10-23

6.  Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2.

Authors:  Anjani Muthyala; Sandeep Sasidharan; Kevin John John; Amos Lal; Ajay K Mishra
Journal:  World J Virol       Date:  2022-09-25

Review 7.  Targeting Regulatory T Cells for Therapy of Lupus Nephritis.

Authors:  Rajkumar Venkatadri; Vikram Sabapathy; Murat Dogan; Rahul Sharma
Journal:  Front Pharmacol       Date:  2022-01-06       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.